CLAV 228.5

CLAV 228.5 is a dispersible antibiotic formulation used for the treatment of bacterial infections, especially in pediatric patients. Each uncoated dispersible tablet contains Amoxycillin (as Amoxycillin Trihydrate) equivalent to 200 mg + Potassium Clavulanate equivalent to Clavulanic Acid 28.5 mg. This combination helps fight infection and overcome bacterial resistance, making it effective in respiratory, ear, and urinary tract infections while supporting faster recovery.